The novel therapy of this peptide represents a exciting advance in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide313199.pointblog.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-94903895